The American Journal of Managed Care19h
FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra
Tocilizumab-anoh is approved for multiple conditions, including rheumatoid arthritis and COVID-19, in intravenous and subcutaneous formulations. Phase 3 study confirmed biosimilarity between ...
Contract Pharma5h
FDA Approves Celltrion’s Biosimilar to ACTEMRA
The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...
centerforbiosimilars4h
FDA Approves Celltrion's Avtozma as Third Tocilizumab Biosimilar
The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.
PipelineReview.com11h
U.S. FDA approves Celltrion’s AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®
JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...
pharmaphorum3d
Biogen claims first with FDA nod for biosimilar Actemra
The intravenous biosimilar of IL-6 inhibitor Actemra (tocilizumab) – called Tofidence (formerly BIIB800) – has been cleared for three of the indications for which Roche’s drug is used ...
pharmaphorum3d
EU has its first RoActemra biosimilar, from Fresenius Kabi
The European Commission has approved the first biosimilar version of Actemra/RoActemra ... offering of both intravenous and subcutaneous formulations of tocilizumab and is targeting the number ...
Medscape4d
Monoclonal Antibodies in Rheumatoid Arthritis
Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis ... that interfere with IL-6 function Tocilizumab is a monoclonal antibody ...
Medscape6d
Tocilizumab: The First Interleukin-6-Receptor Inhibitor
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed. Summary: Tocilizumab is a novel monoclonal antibody that ...
Le Lézard10h
Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) announced today that it has received approval for a partial amendment to the ...
Korea Joongang Daily on MSN13h
Celltrion's Actemra biosimilar gets FDA approval
Celltrion's biosimilar Avtozma, used to treat inflammatory diseases, was approved for the U.S. market by the Food and Drug Administration.
Yonhap News English on MSN16h
Celltrion gets U.S. FDA approval for new biosimilar for autoimmune disease treatment
Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).
Le Lézard1d
CGI enters into an agreement for the acquisition of Novatec, a leading digital services firm in Germany and Spain
CGI , one of the largest independent IT and business consulting services firms in the world, today announced that its wholly-owned limited partnership, ...